Parallax Volatility Advisers, L.P. Novo Cure LTD Call Options Transaction History

Parallax Volatility Advisers, L.P.

$43.7 Billion
Q1 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $387,504 - $539,448	31,200 New	31,200 $487,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $1.78 Million - $3.65 Million	-44,200 Reduced 65.77%	23,000 $954,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $15.6 Million - $32.8 Million	-276,300 Reduced 80.44%	67,200 $4.04 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $8.85 Million - $11.8 Million	138,400 Added 67.48%	343,500 $25.2 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $333,151 - $438,892	4,900 Added 2.45%	205,100 $15.6 Million

Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $9.92 Million - $15.8 Million	175,300 Added 704.02%	200,200 $13.9 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $1.51 Million - $2.12 Million	-25,100 Reduced 50.2%	24,900 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $1.32 Million - $2.15 Million	-17,600 Reduced 26.04%	50,000 $3.75 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $7.85 Million - $13.2 Million	67,600 New	67,600 $7.85 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $8.95 Million - $15 Million	-77,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $10 Million - $17.4 Million	77,000 New	77,000 $17.1 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $45.8 Million - $70.2 Million	-369,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $2.72 Million - $4.16 Million	21,900 Added 6.31%	369,000 $48.8 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $38.9 Million - $60.4 Million	347,100 New	347,100 $60.1 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $5.11 Million - $7.94 Million	-45,600 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $1.13 Million - $2.16 Million	19,400 Added 74.05%	45,600 $5.08 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $1.39 Million - $1.81 Million	24,300 Added 1278.95%	26,200 $1.56 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $690,305 - $1.16 Million	-12,100 Reduced 86.43%	1,900 $127,000
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $1.39 Million - $1.7 Million	-71,900 Reduced 83.7%	14,000 $305,000
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $179,300 - $240,899	-11,000 Reduced 11.35%	85,900 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $1.75 Million - $2.11 Million	96,900	96,900 $1.92 Million

Others Institutions Holding NVCR

# of Institutions

277

Shares Held

73.2M

Call Options Held

1.43M

Put Options Held

832K

Vanguard Group Inc Valley Forge, PA

10M
Shares

$169 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.08M
Shares

$153 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

8.86M
Shares

$150 Million
0.03% of portfolio
State Street Corp Boston, MA

3.36M
Shares

$56.7 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.38M
Shares

$40.1 Million
0.0% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account